• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD FEMORAL HEAD 40MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD FEMORAL HEAD 40MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Model Number 74123140
Device Problem Biocompatibility (2886)
Patient Problems Pain (1994); Ambulation Difficulties (2544); Metal Related Pathology (4530)
Event Date 04/03/2019
Event Type  Injury  
Manufacturer Narrative
Internal complaint reference: case (b)(4).
 
Event Description
Us legal.It was reported that the plaintiff underwent a bhr revision surgery on the left hip on (b)(6) 2019 due to pain, limited mobility, metal staining of the sub-cutaneous bursa tissue, cloudy fluid in the hip joint, cobalt toxicity, and adverse local tissue reaction.The primary left bhr surgery was performed on (b)(6) 2008.The patient current status is unknown.
 
Event Description
It was reported that the plaintiff underwent a bhr revision surgery on the left hip on (b)(6) 2019 due to pain, limited mobility, metal staining of the sub-cutaneous bursa tissue, cloudy fluid in the hip joint, cobalt toxicity, adverse local tissue reaction and mechanical complication of the joint implant.The primary left bhr surgery was performed on (b)(6) 2008.During the revision, the metallic femoral head was explanted, and the system was revised to a tha.The patient was transferred to the recovery room in good condition.
 
Manufacturer Narrative
H10.Additional information in a2, b5, d6b.Internal reference number: (b)(4).
 
Manufacturer Narrative
H3, h6: it was reported that a left hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information has been requested for this complaint but has not become available.Since part/lot details were not received for investigation no thorough manufacturing record review can be performed.If the products or additional information become available in the future, the tasks will be reopened and performed.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.The clinical information provided of the (metal staining of the subcutaneous bursa tissue, cloudy appearing fluid, and synovitis around the margins of the head) may be consistent with a reaction to metal debris.However, the source and the root cause cannot be determined with the available documentation.It cannot be concluded that the reported clinical findings are associated with the implant failure.Without the return of the devices used in treatment or additional information we cannot advance the investigation or confirm this complaint; our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity, unreasonable stress on replacement system.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Event Description
It was reported that the plaintiff underwent a bhr revision surgery on the left hip on 2019 due to pain, limited mobility, metal staining of the sub-cutaneous bursa tissue, cloudy fluid in the hip joint, cobalt toxicity, adverse local tissue reaction and mechanical complication of the joint implant.The primary left bhr surgery was performed on (b)(6) 2008.During the revision, the metallic femoral head was explanted, and the system was revised to a tha.The patient was transferred to the recovery room in good condition.
 
Manufacturer Narrative
H10: additional information in h7 and h9.H3, h6.It was reported that a left hip revision surgery was performed due to pain, limited mobility, metal staining of the sub-cutaneous bursa tissue, cloudy fluid in the hip joint, cobalt toxicity, adverse local tissue reaction and mechanical complication of the joint implant.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the femoral head was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the femoral head, this failure will continue to be monitored.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.Although the reported pain and cobalt toxicity, and intraoperative findings of metal staining, cloudy appearing fluid, and synovitis may be consistent with the reported metallosis, the clinical root cause of the reported clinical reactions cannot be confirmed with the information provided.It cannot be concluded the reported clinical reactions/event was associated with a mal performance of the implant.The patient impact beyond the reported pain, revision and post-revision convalescence period cannot be determined.Based on the available information we can confirm the reported complaint, however without further information our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the device or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.H11: corrected information in h6 (health effect - clinical code and health effect - impact code).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMORAL HEAD 40MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key13362278
MDR Text Key284516041
Report Number3005975929-2022-00029
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010552402
UDI-Public03596010552402
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/30/2013
Device Model Number74123140
Device Catalogue Number74123140
Device Lot Number08EW17066
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/31/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-2745-2015
Patient Sequence Number1
Patient Outcome(s) Other; Hospitalization; Required Intervention;
Patient Age52 YR
Patient SexFemale
-
-